Blastomyces Antibody, Spinal Fluid
Blastomyces dermatitidis is a fungus that causes a disease called blastomycosis, a pulmonary disease that presents with cough, pain, bloody sputum, and fever. Blastomyces dermatitidis is a dimorphic fungus that grows as a white mold. It is usually found in the soil near water, mainly in the southeastern and south central states where the land is mostly marsh. It is in its filamentous form in the soil, from which it produces spores, which are dispersed by the wind or by disturbing the soil. Spores convert to yeast when they are inhaled by a host and find themselves at body temperature in a moist environment, thus leading to infection. Although the most common manifestation of the disease is pneumonia-like symptoms, the infection may spread to the skin, bone, or brain and cause swelling and lesions. In those infected with this organism, approximately 50% are asymptomatic. When left untreated the disease can be fatal. There is an 11% fatality rate in untreated patients and a 6% fatality rate in treated patients.
Immunocompromised patients, such as those that are HIV positive or undergoing chemotherapy, are most susceptible to being infected with the disease and have the most complications leading to death. Detection of Blastomyces dermatitidis infection can be determined by histologic, mycologic, and immunologic methods. Complement fixation and immunodiffusion are very sensitive but cross-reactivity can occur with Histoplasmosis infections. The method of choice for rapid diagnosis of blastomycosis is enzyme immunoassay in urine. This test has shown increased sensitivity and specificity with little cross-reactivity with other fungus such as Histoplasma and Legionella. DNA-amplified PCR assay can be used as a confirmatory assay.
- Diagnosis of blastomyces infection
- Diagnosis of Blastomyces dermatitidis
- Diagnosis of diseases related to blastomyces infection in immunocompromised patients
Positive in:
- Blastomycosis
- Blastomyces dermatitis
- Blastomyces infection in immunocompromised patients
A positive test is indicative of current or prior infection. It is possible for the test to be negative in the "window" following exposure but before antibody has been produced in detectable quantity, or if the patient is immunesuppressed. A negative test should be repeated in 7 to 14 days if there continues to be clinical suspicion of infection. A persistently negative test does not completely rule out the possibility of infection. Serum antibody detects both IgG and IgM. Antibody tests can cross react with Aspergillus, Coccidioides or Histoplasma.
Negative (Non-reactive)
Cerebrospinal fluid collected in sterile container or syringe.
Stability
- Ambient: 24 hours
- Refrigerated: 3-5 days
- Frozen: 60 day
Serum collected at onset of disease and 3-4 weeks later.
- Dermatol Clin. 1989 Apr;7(2):241-50. [PMID: 2670369]
- Clin Infect Dis. 1992 Mar;14 Suppl 1:S82-90. [PMID: 1314106]
- Semin Respir Crit Care Med. 2008 Apr;29(2):174-81. [PMID: 18365999]
- JAMA. 1999; 282(1):21-22. [PMID: 10404898]